Literature DB >> 25794667

Scaling up multidrug-resistant tuberculosis care in China.

Karen R Jacobson1, Lora L Sabin2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25794667      PMCID： PMC4492310          DOI： 10.1016/S2214-109X(15)70093-8

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  7 in total

1.  Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12.

Authors:  Victoria Y Fan; Denizhan Duran; Rachel Silverman; Amanda Glassman
Journal:  Lancet Glob Health       Date:  2013-08-23       Impact factor: 26.763

2.  Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study.

Authors:  Renzhong Li; Yunzhou Ruan; Qiang Sun; Xiexiu Wang; Mingting Chen; Hui Zhang; Yanlin Zhao; Jin Zhao; Cheng Chen; Caihong Xu; Wei Su; Yu Pang; Jun Cheng; Junying Chi; Qian Wang; Yunting Fu; Shitong Huan; Lixia Wang; Yu Wang; Daniel P Chin
Journal:  Lancet Glob Health       Date:  2015-04       Impact factor: 26.763

3.  National survey of drug-resistant tuberculosis in China.

Authors:  Yanlin Zhao; Shaofa Xu; Lixia Wang; Daniel P Chin; Shengfen Wang; Guanglu Jiang; Hui Xia; Yang Zhou; Qiang Li; Xichao Ou; Yu Pang; Yuanyuan Song; Bing Zhao; Hongtao Zhang; Guangxue He; Jing Guo; Yu Wang
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

4.  Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.

Authors:  Karen R Jacobson; Danie Theron; Emily A Kendall; Molly F Franke; Marinus Barnard; Paul D van Helden; Tommie C Victor; Elizabeth M Streicher; Megan B Murray; Robin M Warren
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

5.  Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.

Authors:  Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew Magee; Henry M Blumberg; Russell R Kempker
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

6.  Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data.

Authors:  Lixia Wang; Hui Zhang; Yunzhou Ruan; Daniel P Chin; Yinyin Xia; Shiming Cheng; Mingting Chen; Yanlin Zhao; Shiwen Jiang; Xin Du; Guangxue He; Jun Li; Shengfen Wang; Wei Chen; Caihong Xu; Fei Huang; Xiaoqiu Liu; Yu Wang
Journal:  Lancet       Date:  2014-03-18       Impact factor: 79.321

7.  Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Authors:  Lesley E Scott; Kerrigan McCarthy; Natasha Gous; Matilda Nduna; Annelies Van Rie; Ian Sanne; Willem F Venter; Adrian Duse; Wendy Stevens
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069
  7 in total
  1 in total

1.  Verification of Diagnosis in Tuberculosis: A Case Report and Discussion.

Authors:  Amanda M Dave; Abed Adelrahman; Vishist Mehta; Stephen Cavalieri; Renuga Vivekanadan
Journal:  Cureus       Date:  2017-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.